# Crenessity

NDC: 70370-5250
Generic name: crinecerfont
Labeler / Manufacturer: Neurocrine Biosciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20241213

FDA application: NDA218820

## Active ingredients

- CRINECERFONT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70370-5250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70370-5250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd3a6fbd-9137-428a-ba46-df6606f07d28